TY - JOUR
T1 - Pharmacologic treatment of infants with neonatal abstinence syndrome in community hospitals compared to academic medical centers
AU - Friedman, Hayley
AU - Parkinson, Gregory
AU - Tighiouart, Hocine
AU - Parkinson, Catherine
AU - Tybor, David
AU - Terrin, Norma
AU - Lester, Barry
AU - Harvey-Wilkes, Karen
AU - Davis, Jonathan M.
N1 - Funding Information:
Funding This study was funded by NIDA grants R01DA032889-04 and 1R21DA041706-01 and a grant from the Charles H. Hood Foundation.
Publisher Copyright:
© 2018, Springer Nature America, Inc.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Objective: To compare length of hospital stay (LOS), LOS due to neonatal abstinence syndrome (NAS), and duration of pharmacologic treatment in community or academic settings. Study design: One hundred-two infants exposed to opioids in utero at two community hospitals were compared to 256 from eight academic centers. All infants were managed with non-pharmacologic care followed by similar pharmacologic treatment options. Results: Two hundred-twelve infants received pharmacologic treatment for NAS. Mean LOS (24.7 ± 8.5 vs. 24.5 ± 11.3 days), LOS due to NAS (24.0 ± 8.2 vs. 23.3 ± 9.2 days), and duration of NAS treatment (19.3 ± 8.0 vs. 18.9 ± 9.2 days) were similar in community compared to academic medical centers. Conclusions: No significant differences were found in infants managed in the community compared to academic care settings. These findings support caring for opioid-exposed infants in both community and academic settings with the use of standardized care protocols.
AB - Objective: To compare length of hospital stay (LOS), LOS due to neonatal abstinence syndrome (NAS), and duration of pharmacologic treatment in community or academic settings. Study design: One hundred-two infants exposed to opioids in utero at two community hospitals were compared to 256 from eight academic centers. All infants were managed with non-pharmacologic care followed by similar pharmacologic treatment options. Results: Two hundred-twelve infants received pharmacologic treatment for NAS. Mean LOS (24.7 ± 8.5 vs. 24.5 ± 11.3 days), LOS due to NAS (24.0 ± 8.2 vs. 23.3 ± 9.2 days), and duration of NAS treatment (19.3 ± 8.0 vs. 18.9 ± 9.2 days) were similar in community compared to academic medical centers. Conclusions: No significant differences were found in infants managed in the community compared to academic care settings. These findings support caring for opioid-exposed infants in both community and academic settings with the use of standardized care protocols.
UR - https://www.scopus.com/pages/publications/85053806360
U2 - 10.1038/s41372-018-0230-8
DO - 10.1038/s41372-018-0230-8
M3 - Article
C2 - 30237476
AN - SCOPUS:85053806360
SN - 0743-8346
VL - 38
SP - 1651
EP - 1656
JO - Journal of Perinatology
JF - Journal of Perinatology
IS - 12
ER -